Tuesday, December 2, 2008 - 11:23PM EST

Clinical Trials

11. Irinotecan as first-line chemotherapy in patients with advanced hepatocellular carcinoma: a multicenter phase II study with dose adjustment according to baseline serum bilirubin level.

Author
Boige V; Taieb J; Hebbar M; Malka D; Debaere T; Hannoun L; Magherini E; Mignard D; Poynard T; Ducreux M;
Institution
Gastrointestinal Oncology Unit, Department of Medicine, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France. boige@igr.fr
Journal
Eur J Cancer. 2006 Mar;42(4):456-9. Epub 2006 Jan 20.
Abstract URL
Click here to view abstract

12. Long-term clinical outcome of phase IIb clinical trial of percutaneous injection with holmium-166/chitosan complex (Milican) for the treatment of small hepatocellular carcinoma.

Author
Kim JK; Han KH; Lee JT; Paik YH; Ahn SH; Lee JD; Lee KS; Chon CY; Moon YM;
Institution
Department of Internal Medicine, Yonsei Institute of Gastroenterology, Yonsei Liver Cancer Study Group, Yonsei University College of Medicine, 134 Shinchoin-dong, Seodaemoon-gu, Seoul, Korea 120-752.
Journal
Clin Cancer Res. 2006 Jan 15;12(2):543-8.
Abstract URL
Click here to view abstract

13. Severe complications of radiofrequency ablation therapy for hepatocellular carcinoma: an analysis of 3,891 ablations in 2,614 patients.

Author
Kasugai H; Osaki Y; Oka H; Kudo M; Seki T;
Institution
Department of Gastrointestinal Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan. kasugai-hi@mc.pref.osaka.jp
Journal
Oncology. 2007;72 Suppl 1:72-5. Epub 2007 Dec 13.
Abstract URL
Click here to view abstract

14. Phase I study of sorafenib in Japanese patients with hepatocellular carcinoma.

Author
Furuse J; Ishii H; Nakachi K; Suzuki E; Shimizu S; Nakajima K;
Institution
Division of Hepatobiliary and Pancreatic Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan. jfuruse@east.ncc.go.jp
Journal
Cancer Sci. 2008 Jan;99(1):159-65. Epub 2007 Oct 22.
Abstract URL
Click here to view abstract

15. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?

Author
Livraghi T; Meloni F; Di Stasi M; Rolle E; Solbiati L; Tinelli C; Rossi S;
Institution
Department of Radiology, Ospedale Civile, Vimercate, Milano, Italy. tito.livraghi@aovimercate.org
Journal
Hepatology. 2008 Jan;47(1):82-9.
Abstract URL
Click here to view abstract

16. Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma.

Author
Thomas MB; Chadha R; Glover K; Wang X; Morris J; Brown T; Rashid A; Dancey J; Abbruzzese JL;
Institution
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA. methomas@mdanderson.org
Journal
Cancer. 2007 Sep 1;110(5):1059-67.
Abstract URL
Click here to view abstract

17. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead.

Author
Poon RT; Tso WK; Pang RW; Ng KK; Woo R; Tai KS; Fan ST;
Institution
Department of Surgery, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.
Journal
Clin Gastroenterol Hepatol. 2007 Sep;5(9):1100-8. Epub 2007 Jul 12.
Abstract URL
Click here to view abstract

18. Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin.

Author
Gish RG; Porta C; Lazar L; Ruff P; Feld R; Croitoru A; Feun L; Jeziorski K; Leighton J; Gallo J; Kennealey GT;
Institution
California Pacific Medical Center, San Francisco, CA 94115, USA. gishr@sutterhealth.org
Journal
J Clin Oncol. 2007 Jul 20;25(21):3069-75.
Abstract URL
Click here to view abstract

19. Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial.

Author
Zhang YJ; Liang HH; Chen MS; Guo RP; Li JQ; Zheng Y; Zhang YQ; Lau WY;
Institution
Department of Hepatobiliary Surgery, Cancer Centre of Sun Yat-Sen University, 651 Dongfeng Rd East, Guangzhou 510060, China.
Journal
Radiology. 2007 Aug;244(2):599-607.
Abstract URL
Click here to view abstract

20. Surgical options in the treatment of hepatocellular carcinoma.

Author
Williams R; White J; Croce M; Dilawari R;
Institution
Department of Surgery, University of Tennessee Health Science Center, Memphis, Tennessee 38104, USA. rfwillia@utmem.edu
Journal
Am Surg. 2007 Jul;73(7):658-62; discussion 662-3.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5